Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

CG-223 demonstrates antifibrotic effects in a murine model of pulmonary fibrosis

Nov. 9, 2021

Virulent factors of P. aeruginosa isolates are upregulated under anaerobic conditions

Nov. 9, 2021

Analysis of lung phenotype in rat CF models using flexiVent and X-ray velocimetry

Nov. 8, 2021

New JAK inhibitors patented by Gossamer Bio

Nov. 8, 2021

Researchers develop a cystic fibrosis-related diabetes murine model

Nov. 8, 2021

F508del and G542X cystic fibrosis sheep models exhibit severe phenotype

Nov. 5, 2021

BPN-15477 corrects splicing defect caused by the c.2988G>A variant in CFTR

Nov. 5, 2021

ELD-607 reduces pulmonary inflammation and lung damage in vivo

Nov. 5, 2021

SP-101 administration restores airway epithelial function in cystic fibrosis

Nov. 5, 2021

APTA-1 shows promise in coronavirus-induced acute lung injury model

Nov. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...